• Info
  • Insider Ownership

Insider Trading & Ownership of Troy Cox

Location
Cambridge, MA
Summary
The estimated net worth of Troy Cox is at least $2,132,169 dollars as of 18 Mar 2026. Troy Cox is the Director of SOPHiA GENETICS SA and owns shares of SOPHiA GENETICS SA (SOPH) stock worth about $1.42M. Troy Cox is the Director of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $710.7K.
Signature
/s/ Elimara Brunetto as Attorney-in-Fact for Troy Cox
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Troy Cox and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Troy Cox has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,132,169.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: SOPHiA GENETICS SA ($1,421,487).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Troy Cox

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SOPH SOPHiA GENETICS SA Director $1,421,487 18 Mar 2026
LAB STANDARD BIOTOOLS INC. Director $710,682 26 Feb 2026
SLGC SomaLogic, Inc. Director 05 Jan 2024
ZYME Zymeworks Inc. Director 10 Dec 2024
ZYME Zymeworks Inc. Director 06 May 2021

Insider Transactions Reported by Troy Cox:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored